Sequential Flow Assembly of Unsymmetrical Triaryl Architectures via Aryllithium Interception
The controlled generation and selective interception of aryllithium intermediates remain longstanding challenges due to their extreme reactivity and poor chemoselectivity under conventional batch conditions. Herein, we disclose a catalyst-free continuous-flow strategy that enables rapid halogen-lithium exchange using n-butyllithium (n-BuLi) as the sole activating reagent, followed by immediate and highly chemoselective electrophilic trapping under precisely defined residence times. This approach enables direct functionalization of bifunctional electrophiles bearing both carbonyl (CO) and cyano (CN) groups, affording products in yields up to 94%. Sequential interception within a single flow sequence enables programmable assembly of unsymmetrical triarylmethanol and triarylmethane architectures from simple aryl halides. These frameworks are prevalent in functional molecules, including trityl-based pharmacophores such as S-trityl-l-cysteine and triphenylmethane dyes such as crystal violet and malachite green. Notably, the method enables streamlined access to letrozole-type derivatives in a single flow sequence, highlighting its utility for the rapid construction of pharmaceutically relevant scaffolds. By harnessing microreactor-enabled kinetic control, this platform establishes a modular approach to chemoselective aryl functionalization inaccessible under traditional processing.
Authors
- Mohmmad S. Qenawy (ORCID: https://orcid.org/0000-0003-1921-196X)
- Aiichiro Nagaki (ORCID: https://orcid.org/0000-0002-8264-6205)
- Xianzhu Zhong (ORCID: https://orcid.org/0000-0003-1640-7617)
- Fazilatun Nisa (ORCID: https://orcid.org/0009-0002-6074-0863)
Institutions
- Hokkaido University (JP)
Publication Details
- Journal
- The Journal of Organic Chemistry
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1021/acs.joc.6c02209
- Primary Topic
- Innovative Microfluidic and Catalytic Techniques Innovation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- Ministry of Education, Culture, Sports, Science and Technology
- New Energy and Industrial Technology Development Organization
- Japan Society for the Promotion of Science